Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Clinical trial NCT05904106 · RECRUITING
Trial details
- NCT number
- NCT05904106
- Sponsor
- Technische Universität Dresden
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-07
- Primary completion
- 2028-09-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.